Organisers marked the event’s 20th anniversary by stripping out digital shows in an effort to push quality over quantity.

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

We look at the pros and cons of the often-thorny issue, as well as the implications of what direction an organisation decides ...